Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
0.4734
-0.0469 (-9.01%)
At close: Jan 16, 2026, 4:00 PM EST
0.4602
-0.0132 (-2.79%)
After-hours: Jan 16, 2026, 7:53 PM EST
Autonomix Medical Employees
As of March 31, 2025, Autonomix Medical had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$1,517,455
Market Cap
3.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 11 | 3 | 37.50% |
| Mar 31, 2024 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMIX News
- 10 days ago - Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - GlobeNewsWire
- 27 days ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - GlobeNewsWire
- 4 weeks ago - Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - GlobeNewsWire
- 7 weeks ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - GlobeNewsWire